Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000236624 | SCV000294176 | uncertain significance | not provided | 2016-05-05 | criteria provided, single submitter | clinical testing | The c.1589delT variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations The c.1589delT variant in the INF2 gene causes a frameshift starting with codon Valine 530, changes this amino acid to a Glycine residue and creates a premature Stop codon at position 28 of the new reading frame, denoted p.V530GfsX28. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. However, loss of function is not an established disease mechanism for the INF2 gene. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |